Nobue KITANAKA, Kanayo ARAI, Kaoko TAKEHARA, F. Scott HALL, Kazuo TOMITA, Kento IGARASHI, Tomoaki SATO, George R. UHL, Junichi KITANAKA. Opioid receptor antagonists reduce motivated wheel running behavior in mice. Behavioural Pharmacology. 2024. 35. 2/3. 114-121
Masahiro Oka, Rui Yoshino, Nobue Kitanaka, F Scott Hall, George R Uhl, Junichi Kitanaka. Role of glycogen synthase kinase-3β in dependence and abuse liability of alcohol. Alcohol and Alcoholism. 2024. 59. 2. agad086. doi: 10.1093/alcalc/agad086
Kazuo Tomita, Yukiko Oohara, Kento Igarashi, Junichi Kitanaka, Nobue Kitanaka, Koh-ichi Tanaka, Mehryar, Habibi Roudkenar, Amaneh Mohammadi Roushandeh, Mitsutaka Sugimura, et al. Kamishoyosan and Kamikihito protect against decreased KCC2 expression via neuroinflammation induced by the P. gingivalis lipopolysaccharide treatment in PC-12 cells and improve behavioral abnormalities in male mice. Heliyon. 2023. 9. 12. e22784
Junichi Kitanaka, Nobue Kitanaka, Kazuo Tomita, F. Scott Hall, Kento Igarashi, George R. Uhl, Tomoaki Sato. Glycogen synthase kinase-3 inhibitors block morphine-induced locomotor activation, Straub tail, and depression of rearing in mice via a possible central action. Neurochemical Research. 2023. 48. 7. 2230-2240
Tomita K, Kuwahara Y, Takashi Y, Yamanishi S, Nabika H, Tanaka K, Kitanaka J, Kitanaka N, Takemura M, Nishiyama N, et al. Analysis of oxidative stress response in clinically relevant radioresistant cells. 18th World Congress of Basic and Clinical Pharmacology. 2018
WHO Expert Committee on Drug Dependence Forty-fifth Report (WHO technical report series; 1046)
World Health Organization (Geneva, Switzerland) 2023
Chapter 7. Glycogen synthase kinase-3β and methamphetamine abuse liability (In: Advances in Health and Disease. Volume 55, Lowell T. Duncan (Editor))
Nova Science Publishers, Inc., New York 2022 ISBN:9781685079987
WHO Expert Committee on Drug Dependence Forty-fourth Report (WHO technical report series;1038)
World Health Organization (Geneva, Switzerland) 2022
WHO Expert Committee on Drug Dependence Forty-Third Report (WHO technical report series;1034)
World Health Organization (Geneva, Switzerland) 2021